330 patients randomized as of September 30, 2026, surpassing full trial enrollment target Company re

TORONTO--(BUSINESS WIRE)--OBIO® companies supported through its Capital Access Advisory Program have

Orchestra BioMed Holdings, Inc. (OBIO) witnessed a jump in share price last session on above-average

NEW HOPE, Pa., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) ("O

Payment follows approximately $5 million received in January 2026, bringing total cash proceeds rece

Analysts upgraded Copart, Orchestra BioMed, Illumina, Martin Marietta Materials and Waters, raising

U.S. stocks fell Thursday as the Dow dropped 300+ points; Macy’s slid on weak guidance, while oil ro

U.S. stocks fell, but Wealthfront surged 6.6% after beating Q2 earnings and revenue estimates; Orche

Analysts upgraded SFNC, OBIO, and more.

BTIG analyst Marie Thibault upgrades Orchestra BioMed Hldgs (NASDAQ:OBIO) from Neutral to Buy and

NEW HOPE, Pa., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“O

NEW HOPE, Pa., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orc

NEW HOPE, Pa., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orc

Piper Sandler analyst Matt O'Brien reiterates Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Ove

Orchestra BioMed Holdings, Inc. (OBIO) came out with a quarterly loss of $0.38 per share versus the

Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.38) per share which missed the

Affinity Asset Advisors LLC lessened its holdings in shares of Orchestra BioMed Holdings, Inc. (NASD

Orchestra BioMed is approaching pivotal trial readouts for AVIM Therapy and Virtue SAB, both with st

NEW HOPE, Pa., June 29, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Or

NEW HOPE, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Or

B. Riley Securities analyst Kyle Bauser maintains Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Buy

NEW HOPE, Pa., May 19, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orch

HC Wainwright & Co. analyst Yi Chen reiterates Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Bu

Barclays analyst Matt Miksic maintains Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Overweight and

Orchestra BioMed Holdings, Inc. (OBIO) came out with a quarterly loss of $0.33 per share versus the

Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.33) per share which beat the a

NEW HOPE, Pa., May 12, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orch

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) ("Orchestra BioMed" or the "Company"),

NEW HOPE, Pa., May 12, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orc

$15 million payment fulfills previously scheduled tranche under royalty-based financing agreement, b

Payment fulfills previously disclosed funding commitment of $20 million and supports planned complet

NEW HOPE, Pa., May 06, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orc

Payment fulfills previously disclosed funding commitment of $20 million and supports planned complet

Together, the two BDDs for AVIM Therapy cover indications that encompass both the broader population

Atrioventricular Interval Modulation (“AVIM”) Therapy Food and Drug Administration (“FDA”) Breakthro

Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly earnings of $0.26 per share which beat the a

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO, "Orchestra BioMed" or the "Company")),

  During Wednesday's trading, 103 companies set new 52-week lows.

U.S. stocks traded mixed, with the Dow Jones dropping around 50 points on Thursday. Here are some bi

U.S. stocks traded slightly lower, with the Dow Jones dropping around 30 points on Thursday. Here ar